ENLIGHT:欧洲轻离子强子治疗网络
ENLIGHT于2002年在CERN和ESTRO发起下成立,整合患者选择、临床试验、技术、放射生物学、影像和卫生经济学等强子治疗议题。该网络通过年度会议和EC框架项目(如ULICE、ENVISION及Marie Curie培训网络)推动欧洲粒子治疗研究、跨国访问与教育培训。随着欧洲碳离子和质子中心增加,未来聚焦强化粒子治疗研究、多学科教育培训及技术与生物学研发,并延续与EPTN等网络合作。
要点
- ENLIGHT自2002年起通过年度会议持续整合欧洲强子治疗多学科力量。
- EC FP7项目ULICE、ENVISION及Marie Curie培训网络对强化强子治疗领域起关键作用。
- 未来方向为强化欧洲粒子治疗研究、多学科教育培训及技术与生物学研发。
核心结论
- ENLIGHT通过年度会议和欧洲项目持续推动强子治疗在多学科领域的整合与研究发展。
- 随着欧洲碳离子和质子中心增加,ENLIGHT未来聚焦强化粒子治疗研究、教育培训及技术与生物学研发。
研究设计与样本
- ENLIGHT于2002年由CERN和ESTRO发起成立,涉及医学物理与工程、放射生物学和放射肿瘤学等学科。
- ENLIGHT于2005年前获EC FP5 programme资助,2006年起由CERN与ESTRO及其他伙伴协作协调。
主要发现
- ENLIGHT自2002年建立年度会议结构并延续至今,汇集强子治疗领域不同学科、项目和机构交流最佳实践与研发信息。
- EC FP7 programme(2008-2014)内启动ULICE、ENVISION及Marie Curie ITNs(PARTNER、ENTERVISION)等项目,对强化强子治疗领域起关键作用。
关键数值与推荐
- ENLIGHT工作主要议题包括患者选择、临床试验、技术、放射生物学、影像和卫生经济学。
临床怎么用
- 放射治疗科可关注ENLIGHT年度会议及与EPTN等网络的合作,获取强子治疗最佳实践与研发信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The European Network for Light Ion Hadron Therapy (ENLIGHT) was established in 2002 following various European particle therapy network initiatives during the 1980s and 1990s (e.g. EORTC task group, EULIMA/PIMMS accelerator design). ENLIGHT started its work on major topics related to hadron therapy (HT), such as patient selection, clinical trials, technology, radiobiology, imaging and health economics. It was initiated through CERN and ESTRO and dealt with various disciplines such as (medical) physics and engineering, radiation biology and radiation oncology. ENLIGHT was funded until 2005 through the EC FP5 programme. A regular annual meeting structure was started in 2002 and continues until today bringing together the various disciplines and projects and institutions in the field of HT at different European places for regular exchange of information on best practices and research and development. Starting in 2006 ENLIGHT coordination was continued through CERN in collaboration with ESTRO and other partners involved in HT. Major projects within the EC FP7 programme (2008-2014) were launched for R&D and transnational access (ULICE, ENVISION) and education and training networks (Marie Curie ITNs: PARTNER, ENTERVISION). These projects were instrumental for the strengthening of the field of hadron therapy. With the start of 4 European carbon ion and proton centres and the upcoming numerous European proton therapy centres, the future scope of ENLIGHT will focus on strengthening current and developing European particle therapy research, multidisciplinary education and training and general R&D in technology and biology with annual meetings and a continuously strong CERN support. Collaboration with the European Particle Therapy Network (EPTN) and other similar networks will be pursued.
引用
- Dosanjh M, Amaldi U, Mayer R, et al. ENLIGHT: European network for Light ion hadron therapy. Radiother Oncol. 2018. PMID: 29625810. doi:10.1016/j.radonc.2018.03.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。